NewEdge Advisors’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$316K Buy
19,830
+2,192
+12% +$33.7K ﹤0.01% 2453
2026
Q1
$249K Buy
17,638
+779
+5% +$11.5K ﹤0.01% 2470
2025
Q4
$239K Buy
16,859
+759
+5% +$11K ﹤0.01% 2475
2025
Q3
$238K Buy
16,100
+724
+5% +$10.8K ﹤0.01% 2316
2025
Q2
$233K Buy
+15,376
New +$225K ﹤0.01% 2145

Other funds holding BCAT

NewEdge Advisors's BCAT Position: Q2 2026 in Review

NewEdge Advisors increased its BlackRock Capital Allocation Term Trust (BCAT) stake by 12% in Q2 2026, buying an estimated $33.7K and bringing the position to 19,830 shares worth $316K. The position accounts for ﹤0.01% of the portfolio, ranked #2453.

NewEdge Advisors first reported a position in BCAT in Q2 2025 and has held it in 5 quarters since. 110 funds tracked by Wall St. Rank hold BCAT as of Q2 2026.

  • NewEdge Advisors held 19,830 shares of BlackRock Capital Allocation Term Trust worth $316K as of Q2 2026.
  • NewEdge Advisors bought 2,192 BlackRock Capital Allocation Term Trust shares in Q2 2026, an estimated $33.7K.
  • BlackRock Capital Allocation Term Trust made up ﹤0.01% of NewEdge Advisors's portfolio in Q2 2026, its #2453 holding.
  • NewEdge Advisors first reported a position in BlackRock Capital Allocation Term Trust in Q2 2025 and has held it in 5 quarters since.
  • 110 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.